List view / Grid view
Research & Development (R&D)
Filter the results
A pioneering clinical study will assess the safety, tolerability and effectiveness of CBD in people with Parkinson's-related psychosis.
Ofev, which is under review for the treatment of people with chronic fibrosing interstitial lung diseases (ILDs), has been given Breakthrough Therapy Designation.
Researchers have created an AI model that analyses the citations of studies, predicting their potential for eventual clinical application.
Why has the pharma industry and its talents lost interest in developing new antibiotics?
A new cell therapy has been tested in patients with liver cirrhosis and found no significant adverse effects.
The FDA has approved the first treatment to increase pain-free light exposure in patients with the rare disorder, erythropoietic protoporphyria.
A drug capsule that can carry insulin and protect them from the harsh environment of the gastrointestinal tract has been developed.
The researcher Sir Peter Ratcliffe and two others have been jointly awarded the Nobel Prize for Physiology or Medicine 2019.
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.
The FDA has given the designation to niraparib for the treatment of gene-mutated castration-resistant prostate cancer.
The FDA has announced its approval of Descovy, a PrEP method therapy, to reduce the risk of HIV-1 infection from sex.
New chemical entities are largely insoluble, which creates a significant challenge when formulating new drugs; but scientists have recognised the potential of metal organic frameworks (MOFs) as alternative delivery mechanisms for such drugs.
4 October 2019 | By Mettler-Toledo GmbH
This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur. taking a closer look at their impact and the solutions available to ensure compliance.